# PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange
Canonical URL: https://biopharmsignal.com/news/PRTC/puretech-announces-intention-to-voluntarily-delist-american-depositary-shares-from-nasdaq-and-concentrate-trading-on-the-london-stock-exchange
Ticker: PRTC
Company: PureTech Health
Source: PureTech Health
Published: 2026-04-29 06:00 EST
Original Source URL: https://investors.puretechhealth.com
## Summary

RNS Number: 2947C PureTech Health PLC 29 April 2026   29 April 2026 PureTech Health plc   PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange   PureTech to maintain its primary listing on the London Stock

## Article Body
RNS Number: 2947C PureTech Health PLC 29 April 2026   29 April 2026 PureTech Health plc   PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange   PureTech to maintain its primary listing on the London Stock
## Recent Company News
- 2026-05-13 11:00 EST — [PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference](https://biopharmsignal.com/news/PRTC/puretech-to-showcase-deupirfenidone-program-at-the-american-thoracic-society-international-conference) — Source: PureTech Health
- 2026-05-01 06:00 EST — [PureTech Founded Entity Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering](https://biopharmsignal.com/news/PRTC/puretech-founded-entity-seaport-therapeutics-announces-pricing-of-upsized-initial-public-offering) — Source: PureTech Health
- 2026-04-29 06:01 EST — [PureTech Announces Annual Results for Year Ended December 31, 2025](https://biopharmsignal.com/news/PRTC/puretech-announces-annual-results-for-year-ended-december-31-2025) — Source: PureTech Health
- 2026-04-29 06:00 EST — [PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange](https://biopharmsignal.com/news/PRTC/puretech-announces-intention-to-voluntarily-delist-american-depositary-shares-from-nasdaq-and-concentrate-trading-on-the-london-stock-exchange) — Source: PureTech Health
- 2026-04-27 11:05 EST — [PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors](https://biopharmsignal.com/news/PRTC/puretech-founded-entity-seaport-therapeutics-adds-intra-cellular-therapies-founder-and-ceo-dr-sharon-mates-to-its-board-of-directors) — Source: PureTech Health
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)